Title of article :
Metabolomic characterization of colorectal cancer cell lines highlighting stage-specific alterations during cancer progression
Author/Authors :
Mohd Yusof ، Hazwani Department of Biochemistry and Molecular Medicine - Faculty of Medicine - Universiti Teknologi MARA, Campus Sungai Buloh , Ab-Rahim ، Sharaniza Department of Biochemistry and Molecular Medicine - Faculty of Medicine - Universiti Teknologi MARA, Campus Sungai Buloh , Wan Ngah ، Wan Zurinah Universiti Kebangsaan Malaysia Medical Centre , Nathan ، Sheila Department of Biosciences and Biotechnology - Faculty of Science and Technology - Universiti Kebangsaan Malaysia , Jamal ، A Rahman A UKM Medical Molecular Biology Institute - UKM Medical Centre , Mazlan ، Musalmah Department of Biochemistry and Molecular Medicine - Faculty of Medicine - Universiti Teknologi MARA, Campus Sungai Buloh
From page :
147
To page :
156
Abstract :
Introduction: Metabolomic studies on various colorectal cancer (CRC) cell lines have improved our understanding of the biochemical events underlying the disease. However, the metabolic profile dynamics associated with different stages of CRC progression is still lacking. Such information can provide further insights into the pathophysiology and progression of the disease that will prove useful in identifying specific targets for drug designing and therapeutics. Thus, our study aims to characterize the metabolite profiles in the established cell lines corresponding to different stages of CRC. Methods: Metabolite profiling of normal colon cell lines (CCD 841 CoN) and CRC cell lines corresponding to different stages, i.e., SW 1116 (stage A), HT 29 and SW 480 (stage B), HCT 15 and DLD-1 (stage C), and HCT 116 (stage D), was carried out using liquid chromatography-mass spectrometry (LC-MS). Mass Profiler Professional and Metaboanalyst 4.0 software were used for statistical and pathway analysis. METLIN database was used for the identification of metabolites. Results: We identified 72 differential metabolites compared between CRC cell lines of all the stages and normal colon cells. Principle component analysis and partial least squares discriminant analysis score plot were used to segregate normal and CRC cells, as well as CRC cells in different stages of the disease. Variable importance in projection score identified unique differential metabolites in CRC cells of the different stages. We identified 7 differential metabolites unique to stage A, 3 in stage B, 5 in stage C, and 5 in stage D. Conclusion: This study highlights the differential metabolite profiling in CRC cell lines corresponding to different stages. The identification of the differential metabolites in CRC cells at individual stages will lead to a better understanding of the pathophysiology of CRC development and progression and, hence, its application in treatment strategies.
Keywords :
Cell metabolomics , Metabolites , Colorectal cancer , Stages
Journal title :
Bioimpacts
Journal title :
Bioimpacts
Record number :
2658448
Link To Document :
بازگشت